184 related articles for article (PubMed ID: 25632195)
1. Preoperative CA 125 is significant indicator of curative resection in gastric cancer patients.
Kim DH; Yun HY; Ryu DH; Han HS; Han JH; Yoon SM; Youn SJ
World J Gastroenterol; 2015 Jan; 21(4):1216-21. PubMed ID: 25632195
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH; Jun KH; Jung H; Park IS; Chin HM
Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
[TBL] [Abstract][Full Text] [Related]
3. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
4. Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection.
Liu X; Qiu H; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z; Sun X
Oncotarget; 2016 Jun; 7(23):35446-53. PubMed ID: 27147574
[TBL] [Abstract][Full Text] [Related]
5. Perioperative Serum Carcinoembryonic Antigen Levels Predict Recurrence and Survival of Patients with Pathological T2-4 Gastric Cancer Treated with Curative Gastrectomy.
Uda H; Kanda M; Tanaka C; Kobayashi D; Inaoka K; Tanaka Y; Hayashi M; Iwata N; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
Dig Surg; 2018; 35(1):55-63. PubMed ID: 28441659
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
Lin JX; Wang W; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Zhou ZW; Li P
Ann Surg Oncol; 2018 Sep; 25(9):2703-2712. PubMed ID: 29971670
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence.
Yamamoto M; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
World J Surg; 2016 Aug; 40(8):1904-9. PubMed ID: 26969673
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Preoperative Serum Carbohydrate Antigen 19-9 in Patients With Stage IV Colorectal Cancer.
Ozawa T; Ishihara S; Kawai K; Nozawa H; Yamaguchi H; Kitayama J; Watanabe T
Clin Colorectal Cancer; 2016 Dec; 15(4):e157-e163. PubMed ID: 27245559
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of perioperative leukocyte count in resectable gastric cancer.
Chen XF; Qian J; Pei D; Zhou C; Røe OD; Zhu F; He SH; Qian YY; Zhou Y; Xu J; Xu J; Li X; Ping GQ; Liu YQ; Wang P; Guo RH; Shu YQ
World J Gastroenterol; 2016 Mar; 22(9):2818-27. PubMed ID: 26973420
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Low Weight Affects Long-term Outcomes Following Curative Gastrectomy for Gastric Cancer.
Komatsu S; Kosuga T; Kubota T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
Anticancer Res; 2018 Sep; 38(9):5331-5337. PubMed ID: 30194185
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with early recurrence after curative surgery for gastric cancer.
Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
[TBL] [Abstract][Full Text] [Related]
13. Investigation of serum tumor markers in the diagnosis of gastric cancer.
Fan B; Xiong B
Hepatogastroenterology; 2011; 58(105):239-45. PubMed ID: 21510322
[TBL] [Abstract][Full Text] [Related]
14. Survival impact of postoperative body mass index in gastric cancer patients undergoing gastrectomy.
Lee HH; Park JM; Song KY; Choi MG; Park CH
Eur J Cancer; 2016 Jan; 52():129-37. PubMed ID: 26686912
[TBL] [Abstract][Full Text] [Related]
15. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
16. The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy.
Kim DH; Oh SJ; Oh CA; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
J Surg Oncol; 2011 Nov; 104(6):585-91. PubMed ID: 21695697
[TBL] [Abstract][Full Text] [Related]
17. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment Serum Carbohydrate Antigen 19-9 Concentration Is a Predictor of Survival of Patients Who Have Undergone Curative Resection of Stage IV Rectal Cancer.
Miki H; Akiyoshi T; Ogura A; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Noma H; Saiura A; Fukunaga Y; Ueno M
Dig Surg; 2018; 35(5):389-396. PubMed ID: 28858867
[TBL] [Abstract][Full Text] [Related]
19. High level of preoperative carbohydrate antigen 19-9 is a poor survival predictor in gastric cancer.
Choi AR; Park JC; Kim JH; Shin SK; Lee SK; Lee YC; Chung JB
World J Gastroenterol; 2013 Aug; 19(32):5302-8. PubMed ID: 23983433
[TBL] [Abstract][Full Text] [Related]
20. Monitoring with sensitive tumor markers contributes to decision-making and better prognosis in gastric cancer patients with peritoneal recurrence.
Ohashi T; Komatsu S; Ichikawa D; Kosuga T; Okamoto K; Arita T; Konishi H; Morimura R; Murayama Y; Shiozaki A; Kuriu Y; Ikoma H; Nakanishi M; Fujiwara H; Otsuji E
Int J Clin Oncol; 2017 Oct; 22(5):897-904. PubMed ID: 28488013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
